Lori Siegert Swan, MD - Medicare Dermatology in Lafayette, IN

Lori Siegert Swan, MD is a medicare enrolled "Dermatology" physician in Lafayette, Indiana. She went to Rush Medical College Of Rush University and graduated in 1990 and has 34 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice The Dermatology Group Inc and her current practice location is 2020 Union St, Suite 300, Lafayette, Indiana. You can reach out to her office (for appointments etc.) via phone at (765) 446-0282.

Lori Siegert Swan is licensed to practice in Indiana (license number 01042461) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1518044601.

Contact Information

Lori Siegert Swan, MD
2020 Union St, Suite 300,
Lafayette, IN 47904
(765) 446-0282
(765) 446-8299



Physician's Profile

Full NameLori Siegert Swan
GenderFemale
SpecialityDermatology
Experience34 Years
Location2020 Union St, Lafayette, Indiana
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Lori Siegert Swan attended and graduated from Rush Medical College Of Rush University in 1990
  NPI Data:
  • NPI Number: 1518044601
  • Provider Enumeration Date: 11/01/2006
  • Last Update Date: 07/20/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 3274519210
  • Enrollment ID: I20060118000862

Medical Identifiers

Medical identifiers for Lori Siegert Swan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1518044601NPI-NPPES
070008454OtherINRAILROAD MEDICARE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology 01042461 (Indiana)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
The Dermatology Group Inc640674014119

News Archive

Study: Early-stage melanomas can help predict tumor metastasis

Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues. With few exceptions, however, doctors have little way of determining whether a newly formed tumor is more likely to remain idle or send invader cells to other parts of the body.

Major labeling inaccuracies in cannabidiol extract products

There is a growing demand among consumers for marijuana containing products supposedly providing several health benefits in a range od diseases and conditions. This has spawned thousands of websites that are selling these products online. Many of these contain mislabeled cannabidiol (CBD) or a compound found in cannabis or marijuana finds a new study.

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Compared to the nicotine patch and a placebo, the smoking cessation aids varenicline (marketed as Chantix in the U.S.) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events, reports an international team of researchers in a study published online April 22 in the journal The Lancet.

Orabrush closes $2.5 million investment round

Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.

Medical treatment guidelines for diabetes

Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition of the person.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Lori Siegert Swan allows following entities to bill medicare on her behalf.
Entity NameThe Dermatology Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1780617860
PECOS PAC ID: 6406740141
Enrollment ID: O20190710002447

News Archive

Study: Early-stage melanomas can help predict tumor metastasis

Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues. With few exceptions, however, doctors have little way of determining whether a newly formed tumor is more likely to remain idle or send invader cells to other parts of the body.

Major labeling inaccuracies in cannabidiol extract products

There is a growing demand among consumers for marijuana containing products supposedly providing several health benefits in a range od diseases and conditions. This has spawned thousands of websites that are selling these products online. Many of these contain mislabeled cannabidiol (CBD) or a compound found in cannabis or marijuana finds a new study.

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Compared to the nicotine patch and a placebo, the smoking cessation aids varenicline (marketed as Chantix in the U.S.) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events, reports an international team of researchers in a study published online April 22 in the journal The Lancet.

Orabrush closes $2.5 million investment round

Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.

Medical treatment guidelines for diabetes

Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition of the person.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lori Siegert Swan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lori Siegert Swan, MD
2020 Union St, Suite 300,
Lafayette, IN 47904

Ph: (765) 446-0282
Lori Siegert Swan, MD
2020 Union St, Suite 300,
Lafayette, IN 47904

Ph: (765) 446-0282

News Archive

Study: Early-stage melanomas can help predict tumor metastasis

Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues. With few exceptions, however, doctors have little way of determining whether a newly formed tumor is more likely to remain idle or send invader cells to other parts of the body.

Major labeling inaccuracies in cannabidiol extract products

There is a growing demand among consumers for marijuana containing products supposedly providing several health benefits in a range od diseases and conditions. This has spawned thousands of websites that are selling these products online. Many of these contain mislabeled cannabidiol (CBD) or a compound found in cannabis or marijuana finds a new study.

Bupropion, varenicline drugs do not increase risk of serious neuropsychiatric adverse events

Compared to the nicotine patch and a placebo, the smoking cessation aids varenicline (marketed as Chantix in the U.S.) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events, reports an international team of researchers in a study published online April 22 in the journal The Lancet.

Orabrush closes $2.5 million investment round

Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.

Medical treatment guidelines for diabetes

Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition of the person.

Read more News

› Verified 8 days ago


Dermatology Doctors in Lafayette, IN

Gary P Dillon, MD
Dermatology
Medicare: Not Enrolled in Medicare
Practice Location: 1500 Salem St, Lafayette, IN 47904
Phone: 765-448-8000    Fax: 765-448-7029
Mark Adrian Lake, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 15 Executive Dr, Suite 4, Lafayette, IN 47905
Phone: 765-838-3428    Fax: 765-838-3440
Raymond Kuwahara, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1500 Salem St, Lafayette, IN 47904
Phone: 765-448-8000    Fax: 765-448-8335
Patricia M Dymek, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 2600 Ferry St, Lafayette, IN 47904
Phone: 765-448-8000    
Tamzin A Rosenwasser,
Dermatology
Medicare: Medicare Enrolled
Practice Location: 1500 Salem St, Lafayette, IN 47904
Phone: 765-448-8000    
Joseph Edward Fruland, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 2600 Ferry St, Lafayette, IN 47904
Phone: 765-448-8000    Fax: 765-446-7029

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.